Central African Republic vs Comoros: Access to anti-retroviral drugs, female
Central African Republic
73.0%
in 2024
Comoros
74.0%
in 2024
Central African Republic rank
71st
Comoros rank
69th
Access to anti-retroviral drugs, female over time
- Central African Republic
- Comoros
How they compare
Comoros currently reports 74.0% against 73.0% in Central African Republic, a difference of 1.0%.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Comoros ahead.
Central African Republic ranks 71st and Comoros ranks 69th of 141 countries.
Across the 3 decades both report, Central African Republic averaged higher in 1 and Comoros in 2.
Head to head by decade
| Decade | Central African Republic | Comoros | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.4% | 0.0% | 2.4% | Central African Republic |
| 2010s | 26.1% | 42.4% | 16.3% | Comoros |
| 2020s | 65.6% | 70.2% | 4.6% | Comoros |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Central African Republic or Comoros?
- Comoros, at 74.0% against 73.0% in Central African Republic as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Central African Republic and Comoros?
- 1.0%, with Comoros ahead.
- How many years of comparable data are there for Central African Republic and Comoros?
- 25 years are reported by both, from 2000 to 2024.
- How do Central African Republic and Comoros rank globally for access to anti-retroviral drugs, female?
- Central African Republic ranks 71st and Comoros ranks 69th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.